US Stock MarketDetailed Quotes

MREO Mereo BioPharma

Watchlist

4.2800
+0.0700+1.66%

Close Nov 1 16:00 ET

4.1200
-0.1600-3.74%

Post 19:14 ET

658.49MMarket Cap-17120P/E (TTM)

Mereo BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

(FY)Dec 31, 2018

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-1.93%-7.9M

13.59%-7.99M

56.72%-21.13M

-7.75M

-9.25M

-590.46%-48.82M

81.69%-7.07M

35.87%-38.62M

-116.08%-60.22M

35.85%-27.87M

Net income from continuing operations

-600.00%-12.26M

25.88%-8.95M

30.21%-29.47M

---1.75M

---12.08M

-319.66%-42.22M

108.47%19.22M

-320.76%-226.84M

-13.89%-53.91M

25.39%-47.34M

Operating gains losses

-95.80%38K

-124.81%-165K

117.50%2.1M

--905K

--665K

77.30%-12.01M

-131.68%-52.9M

7,121.50%167M

-3,331.75%-2.38M

-96.07%73.6K

Depreciation and amortization

-5.17%257K

21.15%275K

19.35%1.06M

--271K

--227K

2.60%889K

-60.24%866.47K

5.39%2.18M

4,078.26%2.07M

1.72%49.49K

Other non cash items

-65.97%309K

537.14%306K

-12.51%1.84M

--908K

---70K

-88.38%2.1M

154.15%18.1M

502.09%7.12M

-59.91%1.18M

730.06%2.95M

Change In working capital

118.40%1.66M

-505.93%-1.51M

32.27%-1.59M

---9.03M

--371K

5.55%-2.35M

46.42%-2.49M

53.77%-4.65M

-429.23%-10.05M

-25.19%3.05M

-Change in receivables

74.04%-370K

4.41%-477K

113.15%456K

---1.43M

---499K

-336.14%-3.47M

-513.69%-794.94K

115.66%192.16K

-220.30%-1.23M

189.87%1.02M

-Change in prepaid assets

86.22%-1.3M

-41.10%1.94M

-5.64%502K

---9.4M

--3.29M

--532K

----

-Change in payables and accrued expense

79.60%3.49M

-23.01%-2.81M

-235.04%-1.97M

--1.94M

---2.29M

186.19%1.46M

64.97%-1.7M

45.16%-4.84M

-534.09%-8.82M

-61.03%2.03M

-Change in other current liabilities

-11.11%-160K

-14.71%-156K

34.17%-578K

---144K

---136K

---878K

----

Cash from discontinued investing activities

Operating cash flow

-1.93%-7.9M

13.59%-7.99M

56.72%-21.13M

---7.75M

---9.25M

-590.46%-48.82M

81.69%-7.07M

35.87%-38.62M

-105.11%-60.22M

32.42%-29.36M

Investing cash flow

Cash flow from continuing investing activities

-67.06%-700K

-121.09%-419K

-419K

449.70%1.99M

-127.89%-568.2K

-96.41%2.04M

17,652.73%56.77M

106.32%319.76K

Net PPE purchase and sale

----

--0

----

375.19%1.99M

-3,211.39%-722.06K

20.81%-21.81K

36.18%-27.53K

-99.53%-43.14K

Net intangibles purchase and sale

--1K

-67.06%-700K

---419K

--0

---419K

--0

-93.85%152.51K

--2.48M

--0

Net business purchase and sale

----

--0

-103.65%-482.44K

--13.21M

--0

Net investment purchase and sale

----

--43.09M

--0

Cash from discontinued investing activities

Investing cash flow

--1K

-67.06%-700K

-121.09%-419K

--0

---419K

449.70%1.99M

-127.89%-568.2K

-96.41%2.04M

17,652.73%56.77M

106.32%319.76K

Financing cash flow

Cash flow from continuing financing activities

3,886.50%7.97M

-99.81%200K

121.38%104.8M

732.32%47.34M

-184.35%-7.49M

-105.77%-2.63M

Net issuance payments of debt

----

---3.19M

----

-103.05%-933.95K

1,156.64%30.65M

-602.34%-2.9M

-97.86%577.35K

Net common stock issuance

----

--11.61M

----

--0

286.23%105.99M

2,197.13%27.44M

-2,933.05%-1.31M

-100.21%-43.14K

Cash dividends paid

----

--0

Proceeds from stock option exercised by employees

----

--62.08K

--0

----

Net other financing activities

----

-322.00%-444K

----

163.33%200K

95.35%-315.82K

-581.00%-6.8M

7.60%-997.8K

14.08%-1.08M

Cash from discontinued financing activities

Financing cash flow

----

3,886.50%7.97M

----

-99.81%200K

121.38%104.8M

732.32%47.34M

-184.35%-7.49M

-105.77%-2.63M

Net cash flow

Beginning cash position

-18.64%48.66M

-15.78%57.42M

-46.48%68.18M

--59.81M

--68.18M

302.21%127.4M

42.18%31.67M

-32.15%22.28M

-48.29%32.83M

-12.30%63.5M

Current changes in cash

605.76%38.88M

10.10%-8.69M

70.88%-13.58M

---7.69M

---9.67M

-148.00%-46.63M

803.50%97.16M

198.27%10.75M

65.45%-10.94M

-990.15%-31.67M

Effect of exchange rate changes

-112.65%-107K

-105.41%-70K

122.40%2.82M

--846K

--1.29M

-700.22%-12.58M

-50.03%-1.57M

-129.03%-1.05M

-779.57%-457.6K

97.22%-52.03K

End cash Position

65.07%87.43M

-18.64%48.66M

-15.78%57.42M

--52.97M

--59.81M

-46.43%68.18M

297.90%127.27M

49.22%31.98M

-32.55%21.43M

-53.02%31.78M

Free cash flow

-1.92%-7.9M

10.10%-8.69M

55.87%-21.55M

---7.75M

---9.67M

-526.66%-48.83M

79.84%-7.79M

35.86%-38.65M

-104.90%-60.25M

36.83%-29.4M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019	(FY)Dec 31, 2018
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-1.93%-7.9M	13.59%-7.99M	56.72%-21.13M	-7.75M	-9.25M	-590.46%-48.82M	81.69%-7.07M	35.87%-38.62M	-116.08%-60.22M	35.85%-27.87M
Net income from continuing operations	-600.00%-12.26M	25.88%-8.95M	30.21%-29.47M	---1.75M	---12.08M	-319.66%-42.22M	108.47%19.22M	-320.76%-226.84M	-13.89%-53.91M	25.39%-47.34M
Operating gains losses	-95.80%38K	-124.81%-165K	117.50%2.1M	--905K	--665K	77.30%-12.01M	-131.68%-52.9M	7,121.50%167M	-3,331.75%-2.38M	-96.07%73.6K
Depreciation and amortization	-5.17%257K	21.15%275K	19.35%1.06M	--271K	--227K	2.60%889K	-60.24%866.47K	5.39%2.18M	4,078.26%2.07M	1.72%49.49K
Other non cash items	-65.97%309K	537.14%306K	-12.51%1.84M	--908K	---70K	-88.38%2.1M	154.15%18.1M	502.09%7.12M	-59.91%1.18M	730.06%2.95M
Change In working capital	118.40%1.66M	-505.93%-1.51M	32.27%-1.59M	---9.03M	--371K	5.55%-2.35M	46.42%-2.49M	53.77%-4.65M	-429.23%-10.05M	-25.19%3.05M
-Change in receivables	74.04%-370K	4.41%-477K	113.15%456K	---1.43M	---499K	-336.14%-3.47M	-513.69%-794.94K	115.66%192.16K	-220.30%-1.23M	189.87%1.02M
-Change in prepaid assets	86.22%-1.3M	-41.10%1.94M	-5.64%502K	---9.4M	--3.29M	--532K	----	----	----	----
-Change in payables and accrued expense	79.60%3.49M	-23.01%-2.81M	-235.04%-1.97M	--1.94M	---2.29M	186.19%1.46M	64.97%-1.7M	45.16%-4.84M	-534.09%-8.82M	-61.03%2.03M
-Change in other current liabilities	-11.11%-160K	-14.71%-156K	34.17%-578K	---144K	---136K	---878K	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-1.93%-7.9M	13.59%-7.99M	56.72%-21.13M	---7.75M	---9.25M	-590.46%-48.82M	81.69%-7.07M	35.87%-38.62M	-105.11%-60.22M	32.42%-29.36M
Investing cash flow
Cash flow from continuing investing activities	1K	-67.06%-700K	-121.09%-419K	0	-419K	449.70%1.99M	-127.89%-568.2K	-96.41%2.04M	17,652.73%56.77M	106.32%319.76K
Net PPE purchase and sale	----	----	--0	----	----	375.19%1.99M	-3,211.39%-722.06K	20.81%-21.81K	36.18%-27.53K	-99.53%-43.14K
Net intangibles purchase and sale	--1K	-67.06%-700K	---419K	--0	---419K	--0	-93.85%152.51K	--2.48M	--0	--0
Net business purchase and sale	----	----	----	----	----	----	--0	-103.65%-482.44K	--13.21M	--0
Net investment purchase and sale	----	----	----	----	----	----	----	----	--43.09M	--0
Cash from discontinued investing activities
Investing cash flow	--1K	-67.06%-700K	-121.09%-419K	--0	---419K	449.70%1.99M	-127.89%-568.2K	-96.41%2.04M	17,652.73%56.77M	106.32%319.76K
Financing cash flow
Cash flow from continuing financing activities			3,886.50%7.97M			-99.81%200K	121.38%104.8M	732.32%47.34M	-184.35%-7.49M	-105.77%-2.63M
Net issuance payments of debt	----	----	---3.19M	----	----	----	-103.05%-933.95K	1,156.64%30.65M	-602.34%-2.9M	-97.86%577.35K
Net common stock issuance	----	----	--11.61M	----	----	--0	286.23%105.99M	2,197.13%27.44M	-2,933.05%-1.31M	-100.21%-43.14K
Cash dividends paid	----	----	----	----	----	----	--0	--0	--0	--0
Proceeds from stock option exercised by employees	----	----	----	----	----	----	--62.08K	--0	--0	----
Net other financing activities	----	----	-322.00%-444K	----	----	163.33%200K	95.35%-315.82K	-581.00%-6.8M	7.60%-997.8K	14.08%-1.08M
Cash from discontinued financing activities
Financing cash flow	----	----	3,886.50%7.97M	----	----	-99.81%200K	121.38%104.8M	732.32%47.34M	-184.35%-7.49M	-105.77%-2.63M
Net cash flow
Beginning cash position	-18.64%48.66M	-15.78%57.42M	-46.48%68.18M	--59.81M	--68.18M	302.21%127.4M	42.18%31.67M	-32.15%22.28M	-48.29%32.83M	-12.30%63.5M
Current changes in cash	605.76%38.88M	10.10%-8.69M	70.88%-13.58M	---7.69M	---9.67M	-148.00%-46.63M	803.50%97.16M	198.27%10.75M	65.45%-10.94M	-990.15%-31.67M
Effect of exchange rate changes	-112.65%-107K	-105.41%-70K	122.40%2.82M	--846K	--1.29M	-700.22%-12.58M	-50.03%-1.57M	-129.03%-1.05M	-779.57%-457.6K	97.22%-52.03K
End cash Position	65.07%87.43M	-18.64%48.66M	-15.78%57.42M	--52.97M	--59.81M	-46.43%68.18M	297.90%127.27M	49.22%31.98M	-32.55%21.43M	-53.02%31.78M
Free cash flow	-1.92%-7.9M	10.10%-8.69M	55.87%-21.55M	---7.75M	---9.67M	-526.66%-48.83M	79.84%-7.79M	35.86%-38.65M	-104.90%-60.25M	36.83%-29.4M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	Unqualified Opinion	--	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes	Unqualified Opinion with Explanatory Notes

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data